Showing results (911-920 of 1,990) with videos related to
Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|August 2, 2020
Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonistDavid Margel, Yaara Ber, Avivit Peer, et al.Prostate Cancer and Prostatic Diseases|July 22, 2020
Management of prostate cancer patients during COVID-19 pandemicCan Obek, Tunkut Doganca, Omer Burak Argun, et al.Prostate Cancer and Prostatic Diseases|May 21, 2014
BMI is associated with larger index tumors and worse outcome after radical prostatectomyN Hayashi, M Matsushima, M Kido, et al.Prostate Cancer and Prostatic Diseases|January 29, 2014
The association of tumor volume with mortality following radical prostatectomyJ J Knoedler, R J Karnes, R H Thompson, et al.Prostate Cancer and Prostatic Diseases|January 29, 2014
ERG rearrangement and protein expression in the progression to castration-resistant prostate cancerJ R Gsponer, M Braun, V J Scheble, et al.Prostate Cancer and Prostatic Diseases|February 11, 2015
Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysisA D Raval, D Thakker, A Vyas, et al.Prostate Cancer and Prostatic Diseases|July 9, 2020
Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zoneJames Steven Wysock, Ezequiel Becher, Rozalba Gogaj, et al.Prostate Cancer and Prostatic Diseases|July 25, 2012
The impact of county-level radiation oncologist density on prostate cancer mortality in the United StatesS Aneja, J B YuProstate Cancer and Prostatic Diseases|January 28, 2015
Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissueJ G Baust, J C Bischof, S Jiang-Hughes, et al.Prostate Cancer and Prostatic Diseases|June 27, 2012
AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasureK A Bolam, D A Galvão, N Spry, et al.Pageof 199